In a phase 3 study, the mean hemoglobin change from baseline to average was significantly higher among roxadustat-treated patients compared with epoetin alfa recipients, according to investigators.
In a study of patients with advanced chronic kidney disease and resistant hypertension, a significantly higher proportion of patients taking patiromer vs placebo remained on spironolactone after 12 weeks.
In a study, serum bicarbonate levels less than 22 mEq/L were associated with an increased incidence of major adverse cardiovascular events.
First-ever randomized controlled trial of a treatment for calciphylaxis demonstrated improvements in survival, pain, and lesion size.
From 1998–2000 to 2016–2018, the overall rate of live donor kidney transplantation for women declined from significantly from 41.9% to 36.7%.
In a study, frail patients had about twice the risk for prolonged recovery from hemodialysis than non-frail patients, who appear to have more resiliency.
In a study, longer dialysis recovery times were associated with higher rates of hospital admission.
In a study, kidney disease patients who regularly used PPIs had increased risk for kidney function decline.
In a study of hemodialysis patients, hypercalcemia accompanied by high parathyroid hormone levels was associated with nearly 2.6-fold increased odds of intradialytic hypotension.
Low hemoglobin levels prior to cardiac surgery or admission to an intensive care unit increases the risk of major adverse kidney events within 7 days, a study found.
